Catechol-O-methyltransferase loss drives cell-specific nociceptive signaling via the enteric catechol-O-methyltransferase/microRNA-155/tumor necrosis factor α axis

QQ Zhou, L Yang, ML Verne, BB Zhang, J Fields… - Gastroenterology, 2023 - Elsevier
Background & Aims The etiology of abdominal pain in postinfectious, diarrhea-predominant
irritable bowel syndrome (PI-IBS-D) is unknown, and few treatment options exist. Catechol-O …

Enteroendocrine Cell Loss Drives Small Intestinal Hypomotility in Colitis

J Gonzales - Cellular and Molecular Gastroenterology and …, 2024 - cmghjournal.org
Inflammatory bowel diseases (IBDs), such as Crohn's disease and Q8 ulcerative colitis, are
characterized by chronic Q9 intestinal inflammation associated with abdominal pain …

[HTML][HTML] Colitis-induced small intestinal hypomotility is dependent on enteroendocrine cell loss in mice

Z Raouf, SN Steinway, D Scheese, CM Lopez… - Cellular and Molecular …, 2024 - Elsevier
Background & Aims The abdominal discomfort experienced by patients with colitis may be
attributable in part to the presence of small intestinal dysmotility, yet mechanisms linking …

[HTML][HTML] Colitis-induced microbial perturbation promotes postinflammatory visceral hypersensitivity

N Esquerre, L Basso, M Defaye, FA Vicentini… - Cellular and molecular …, 2020 - Elsevier
Background & Aims Despite achieving endoscopic remission, more than 20% of
inflammatory bowel disease patients experience chronic abdominal pain. These patients …

Activation of colo‐rectal high‐threshold afferent nerves by Interleukin‐2 is tetrodotoxin‐sensitive and upregulated in a mouse model of chronic visceral hypersensitivity

MA Campaniello, AM Harrington… - …, 2016 - Wiley Online Library
Background Chronic visceral pain is a defining feature of irritable bowel syndrome (IBS). IBS
patients often show alterations in innate and adaptive immune function which may contribute …

[HTML][HTML] MicroRNA-200a targets cannabinoid receptor 1 and serotonin transporter to increase visceral hyperalgesia in diarrhea-predominant irritable bowel syndrome …

Q Hou, Y Huang, C Zhang, S Zhu, P Li… - Journal of …, 2018 - ncbi.nlm.nih.gov
Methods We established the IBS-D rat model and evaluated it using the nociceptive visceral
hypersensitivity test, myeloperoxidase activity assay, restraint stress-induced defecation …

5-oxoETE triggers nociception in constipation-predominant irritable bowel syndrome through MAS-related G protein–coupled receptor D

T Bautzova, JRF Hockley, T Perez-Berezo, J Pujo… - Science …, 2018 - science.org
Irritable bowel syndrome (IBS) is a common gastrointestinal disorder that is characterized by
chronic abdominal pain concurrent with altered bowel habit. Polyunsaturated fatty acid …

[HTML][HTML] Pathophysiological Commonality Between Irritable Bowel Syndrome and Metabolic Syndrome: Role of Corticotropin-releasing Factor–Toll-like Receptor 4 …

T Nozu, T Okumura - Journal of neurogastroenterology and motility, 2022 - ncbi.nlm.nih.gov
Irritable bowel syndrome (IBS) displays chronic abdominal pain with altered defecation.
Most of the patients develop visceral hypersensitivity possibly resulting from impaired gut …

Colonic migrating motor complexes are inhibited in acute tri-nitro benzene sulphonic acid colitis

BR Hofma, HR Wardill, C Mavrangelos… - PLoS …, 2018 - journals.plos.org
Background Inflammatory Bowel Disease (IBD) is characterized by overt inflammation of the
intestine and is typically accompanied by symptoms of bloody diarrhea, abdominal pain and …

[HTML][HTML] Metabolomics: the key to unraveling the role of the microbiome in visceral pain neurotransmission

A Shute, DG Bihan, IA Lewis, Y Nasser - Frontiers in Neuroscience, 2022 - frontiersin.org
Inflammatory bowel disease (IBD), comprising Crohn's disease and Ulcerative colitis, is a
relapsing and remitting disease of the gastrointestinal tract, presenting with chronic …